Scott Doncaster, Marc Sauer,
The development and production of mRNA therapeutics and vaccines requires expertise in both chemical synthesis and microbial fermentation. CDMOs with expertise in both are ideally positioned to ...
Rob Burgess, Ph.D.
Recombinant proteins and antibodies play a considerable range of roles across biopharma and the life sciences. We perhaps most often think about recombinant proteins and antibodies as ...
Thomas Kipping, Ph.D.
Additive manufacturing, which includes three-dimensional printing (3DP), offers many potential benefits to drug makers, including more efficient continuous production of complex drug products ...
Tonia Becker
Significant leaps in therapeutic innovation begin with a series of long-term scientific discoveries. Translating that innovation and those discoveries into the lab, clinical development, and ...
Ryan Larson, Ph.D.
Cell therapies offer significant therapeutic potential across oncology, including for both hematological malignancies and solid tumors. However, challenges remain in optimizing access and ...
William Leonardi, Ph.D.
Pre-License Inspections (PLIs) are performed as part of the Biologics License Application (BLA) approval process to confirm that the biologic drug product is being manufactured and released in ...
Almut von der Brelie
Taste-masking of bitter active pharmaceutical ingredients (APIs) is essential for achieving medication adherence for oral dosage forms. High-intensity sweeteners provide an effective means for ...
Chris McClain
Personalized gene-modified cell therapies are expensive and complex treatments, and numerous factors contribute to their success or failure for individual patients. A means for predicting ...
The Pharma’s Almanac editorial team is very excited to present our Q3 digital issue, which features new content from our team and our colleagues at Nice Insight on a range of trending topics and from some truly remarkable subject matter experts from across the pharma/biopharma ecosystem, including drug discovery and development companies, life science industrials, technology providers, consultants, and contract development and manufacturing organizations. The featured articles address topics that span the biopharmaceutical value chain, threaded throughout with reminders to always consider the patient, throughout discovery, formulation, manufacturing, and beyond.
Scorpion Biological Services Becomes Scorpius BioManufacturing to Reflect Expansion
Hovione and GEA Announce a Strategic Collaboration to Advance Continuous Tableting
Check out the top 100 articles and trending topics our subscribers are reading right now.
Discover which PA contributors have had the most readers.
Find out which companies have been viewed the most in each industry segment.
View more about the industry-leading companies who contributed to Pharma's Almanac.
View Full Company Directory